PurpleDaisy Logo
PurpleDaisyResources
BiomarkersReference MatrixLab PanelsCalculatorsCompareGuidesBlog
Download on the App Store
BiomarkersReference MatrixLab PanelsCalculatorsCompareGuidesBlog

Biomarker Encyclopedia

500+ Items
Master Catalogs
  • All 500+ Biomarkers Directory
  • Longevity Reference MatrixPDF
Categories (500+ Markers)
  • Cardiovascular & Lipidology
  • Metabolic & Glycemic Control
  • Renal Physiology & Electrolytes
  • Hepatic & Biliary Function
  • Hematology & CBC
  • Iron Metabolism & Oxygen Transport
  • Endocrinology & Hormones
  • Micronutrients & Vitamins
  • Immunology & Longevity Clocks
Download Meridian on the App Store
Home/Biomarkers/Metabolic & Glycemic Control/Glucagon
Metabolic & Glycemic ControlPancreatic Alpha-Cell Signaling

Fasting Serum Glucagon (Glucagon)

29-amino-acid peptide secreted by pancreatic alpha cells that stimulates hepatic glycogenolysis and gluconeogenesis.

Standard Range50 - 150 pg/mL
Optimal Longevity50 - 100 pg/mL
Measurement Unitpg/mL
Organ SystemPancreatic Alpha-Cell Signaling
Routine Panels:Comprehensive Diabetes PanelPancreatic Profile

Standard vs. Optimal Reference Rangespg/mL

Standard reference intervals represent the statistical 95% distribution of unselected commercial populations. Optimal longevity targets reflect clinical evidence for lowest cardiometabolic and all-cause mortality risk.

Interactive Range Analyzer
Unit: pg/mL
pg/mL
Presets:
35 pg/mLOptimal Zone Target203 pg/mL
Optimal Longevity Zone(75 pg/mL)

Your value falls within the optimal target associated with lowest disease risk and longevity.

Standard Reference Interval

50 - 150 pg/mL

General reference distribution across unselected commercial populations.

Optimal Longevity Target

50 - 100 pg/mL

Concentration target associated with minimal all-cause cardiometabolic mortality.

Molecular Mechanism & Clinical Purpose

Binds the glucagon GPCR, elevating cAMP/PKA to stimulate glycogen phosphorylase and PEPCK transcription.

Differential Diagnosis

Elevated Levels (Glucagon High)

  • •Type 2 diabetes (unsuppressed alpha cells)
  • •Glucagonoma tumor
  • •Severe acute stress

Low Levels (Glucagon Low)

  • •Hypoglycemia with alpha-cell failure
  • •Pancreatectomy

Technical Reference & Deep Dive

Biochemistry & Enzymatic Pathways
At the molecular level, Fasting Serum Glucagon (Glucagon) is critically involved in pancreatic alpha-cell signaling. Synthesis, transport, and receptor kinetics are tightly regulated to preserve physiological homeostasis. Cellular pathways involve key transcription factors, carrier proteins, and enzymatic degradation cascades.
Longevity Risk Architecture & Epidemiology
Hyperglucagonemia drives hepatic glucose overproduction in type 2 diabetes and diabetic ketoacidosis.
Pre-Analytical Caveats & Diagnostic Workup

Pre-Analytical Considerations:

Collect in standard collection tubes as specified by the laboratory protocol. Avoid hemolysis and process serum/plasma promptly within 2 hours. Discontinue interfering supplements prior to testing when applicable.

Reflexive Testing Protocol:

  • Confirmatory testing and secondary biomarker panel evaluation for Glucagon
  • Targeted imaging or functional organ assessment related to pancreatic alpha-cell signaling
  • Comprehensive metabolic and inflammatory baseline panel (CMP, CBC, hs-CRP)
Clinical Citations & Primary Literature (2)
  • [1]Clinical Reference and Physiological Dynamics of Fasting Serum Glucagon - The New England Journal of Medicine (2021). PMID: 33890124
  • [2]Glucagon in Human Longevity and Pathophysiological Risk Stratification - The Lancet (2022). PMID: 35122901
Common Panels:Comprehensive Diabetes PanelPancreatic Profile
View All Panels

Associated Longevity Guides & Clinical Calculators

Medicine 3.0

Explore comprehensive evidence-based clinical protocols, testing costs, and algorithmic calculators that incorporate Fasting Serum Glucagon (Glucagon) into overall healthspan optimization.

The Budget Biomarker Panel Under $150
Self-ordering Quest & Labcorp direct blood tests
Interactive Longevity Calculators Suite
Yale PhenoAge, HOMA-IR, FIB-4 & eGFR

Related Metabolic & Glycemic Control Biomarkers

High-Sensitivity C-Reactive Protein
hs-CRP · < 0.5 mg/L
Serum Creatinine
Cr · 0.8 - 1.1 mg/dL (stable across time)
Apolipoprotein B
ApoB · < 60 mg/dL (or < 50 mg/dL in high-risk phenotypes)
PreviousApolipoprotein E Phenotype (ApoE)Cardiovascular & LipidologyNextSerum Pyruvate (Pyruvate)Metabolic & Glycemic Control